Suppression of IL-2 induction of NK cell cytotoxicity and IFNγ secretion by IL-6 and TGFβ1 in neuroblastoma/monocyte-conditioned medium is prevented by lenalidomide. The gene discussed is IL6; the disease is neuroblastoma.